Brian Wilson was the most noteworthy name among those who were non-tendered last night. There’s still a chance he could return to the Giants at a discounted rate, but Henry Schulman of the San Francisco Chronicle hears that his tenure in San Francisco is almost certainly over.
The Giants technically can negotiate a lower-priced, incentive-rich deal with Wilson now that he is a free agent, but multiple sources said the 30-year-old right-hander is upset about the Giants’ stance and has told people he will sign elsewhere.
Wilson made an $8.5 million salary this past season and the Giants weren’t willing to offer him the minimum guarantee of $6.8 million through arbitration coming off his second Tommy John surgery. While Wilson apparently took issue with that, it was an understandable decision from a business perspective, as the Giants’ bullpen is already pretty expensive and $6.8 million is a lot to guarantee to a reliever, especially one who is still rehabbing from surgery.
Wilson figures to land a deal similar in structure to Ryan Madson’s one-year contract with the Angels, which includes a $3.5 million base salary and $3.5 million in possible incentives based on days spent on the roster and games finished. The Dodgers and Red Sox have been mentioned as two possible landing spots.
Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.
Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.
The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.
It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.
The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.
Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.